Home LiteratureArticle Details
PMID: 15870333 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Heterologous expression of novobiocin and clorobiocin biosynthetic gene clusters.

Applied and environmental microbiology ·Vol. 71 ·No. 5 ·2005-05-00 ·Pages 2452-9

Eustáquio AS, Gust B, Galm U, Li SM, Chater KF, Heide L

Abstract

A method was developed for the heterologous expression of biosynthetic gene clusters in different Streptomyces strains and for the modification of these clusters by single or multiple gene replacements or gene deletions with unprecedented speed and versatility. Lambda-Red-mediated homologous recombination was used for genetic modification of the gene clusters, and the attachment site and integrase of phage phiC31 were employed for the integration of these clusters into the heterologous hosts. This method was used to express the gene clusters of the aminocoumarin antibiotics novobiocin and clorobiocin in the well-studied strains Streptomyces coelicolor and Streptomyces lividans, which, in contrast to the natural producers, can be easily genetically manipulated. S. coelicolor M512 derivatives produced the respective antibiotic in yields comparable to those of natural producer strains, whereas S. lividans TK24 derivatives were at least five times less productive. This method could also be used to carry out functional investigations. Shortening of the cosmids' inserts showed which genes are essential for antibiotic production.

MeSH Terms
Amino Acid Sequence Escherichia coli/genetics Molecular Sequence Data Multigene Family Novobiocin/analogs & derivatives,biosynthesis Recombination, Genetic Streptomyces/genetics,metabolism
Chemicals
Novobiocin clorobiocin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Eustáquio Alessandra S
Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
Gust Bertolt
Galm Ute
Li Shu-Ming
Chater Keith F
Heide Lutz
References (31)
31 references, click to expand
  1. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    J Natl Cancer Inst. 2000 Feb 2;92(3):242-8 PMID: 10655441
  2. Antibiotics and prevention of microbial colonization of catheters.
    Antimicrob Agents Chemother. 1995 Nov;39(11):2397-400 PMID: 8585715
  3. Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2).
    J Bacteriol. 1996 Dec;178(24):7276-84 PMID: 8955413
  4. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2.
    Cancer. 1998 Jan 15;82(2):403-11 PMID: 9445199
  5. Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891.
    Antimicrob Agents Chemother. 2000 May;44(5):1214-22 PMID: 10770754
  6. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 PMID: 10829079
  7. Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31.
    Mol Microbiol. 2000 Oct;38(2):232-41 PMID: 11069650
  8. Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16).
    Oncol Res. 2000;12(3):113-9 PMID: 11216669
  9. Modulation of actinorhodin biosynthesis in Streptomyces lividans by glucose repression of afsR2 gene transcription.
    J Bacteriol. 2001 Apr;183(7):2198-203 PMID: 11244057
  10. Coumarin formation in novobiocin biosynthesis: beta-hydroxylation of the aminoacyl enzyme tyrosyl-S-NovH by a cytochrome P450 NovI.
    Chem Biol. 2001 Apr;8(4):301-12 PMID: 11325587
  11. The role of ABC transporters in antibiotic-producing organisms: drug secretion and resistance mechanisms.
    Res Microbiol. 2001 Apr-May;152(3-4):341-50 PMID: 11421281
  12. Novobiocin is a novel inducer of CD38 on cells of the myelomonocytic lineage.
    Biochim Biophys Acta. 2002 Jan 30;1542(1-3):32-40 PMID: 11853877
  13. Combinatorial biosynthesis of antibiotics: challenges and opportunities.
    Chembiochem. 2002 Mar 1;3(2-3):125-34 PMID: 11921390
  14. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2).
    Nature. 2002 May 9;417(6885):141-7 PMID: 12000953
  15. Biosynthesis of simocyclinone D8 in an 18O2-rich atmosphere.
    J Antibiot (Tokyo). 2002 Mar;55(3):341-2 PMID: 12014451
  16. The streptomyces genome contains multiple pseudo-attB sites for the (phi)C31-encoded site-specific recombination system.
    J Bacteriol. 2002 Oct;184(20):5746-52 PMID: 12270833
  17. Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.
    Microbiology. 2002 Dec;148(Pt 12):3901-11 PMID: 12480894
  18. PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1541-6 PMID: 12563033
  19. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
    Antimicrob Agents Chemother. 2003 Mar;47(3):869-77 PMID: 12604514
  20. Clorobiocin biosynthesis in Streptomyces: identification of the halogenase and generation of structural analogs.
    Chem Biol. 2003 Mar;10(3):279-88 PMID: 12670542
  21. Novobiocin biosynthesis: inactivation of the putative regulatory gene novE and heterologous expression of genes involved in aminocoumarin ring formation.
    Arch Microbiol. 2003 Jul;180(1):25-32 PMID: 12736771
  22. Natural products as sources of new drugs over the period 1981-2002.
    J Nat Prod. 2003 Jul;66(7):1022-37 PMID: 12880330
  23. Identification of a topoisomerase IV in actinobacteria: purification and characterization of ParYR and GyrBR from the coumermycin A1 producer Streptomyces rishiriensis DSM 40489.
    Microbiology. 2004 Mar;150(Pt 3):641-7 PMID: 14993313
  24. Where will new antibiotics come from?
    Nat Rev Microbiol. 2003 Oct;1(1):65-70 PMID: 15040181
  25. In vitro and in vivo production of new aminocoumarins by a combined biochemical, genetic, and synthetic approach.
    Chem Biol. 2004 Feb;11(2):173-83 PMID: 15123279
  26. Cloning and characterization of a DNA gyrase B gene from Streptomyces sphaeroides that confers resistance to novobiocin.
    EMBO J. 1988 Jul;7(7):2255-9 PMID: 2843361
  27. Cloning and expression in a heterologous host of the complete set of genes for biosynthesis of the Streptomyces coelicolor antibiotic undecylprodigiosin.
    Gene. 1990 Sep 1;93(1):91-9 PMID: 2227430
  28. Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector.
    Gene. 1992 Feb 1;111(1):61-8 PMID: 1547955
  29. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Antimicrob Agents Chemother. 1993 Jun;37(6):1334-42 PMID: 8328783
  30. The interaction between coumarin drugs and DNA gyrase.
    Mol Microbiol. 1993 Aug;9(4):681-6 PMID: 8231802
  31. afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2).
    Mol Microbiol. 1996 Jul;21(2):385-96 PMID: 8858592
Article Info
Journal
Applied and environmental microbiology
Abbr.
Appl Environ Microbiol
ISSN
0099-2240
Published
2005-05-00
Pages
2452-9
Language
English
Region
United States
NLM ID
7605801
PMCID
PMC1087579
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com